Skip to main content
Top
Published in: Clinical Journal of Gastroenterology 1/2013

01-02-2013 | Case Report

A case of IgG4-related disease associated with diffuse large B cell lymphoma

Authors: Toshiyuki Mitsuyama, Akiyoshi Nishio, Makoto Takaoka, Kazushige Uchida, Masaaki Shimatani, Toshiro Fukui, Tsukasa Ikeura, Masaki Koyabu, Hideaki Miyoshi, Takeo Kusuda, Akiko Kurishima, Yuri Fukui, Kimi Sumimoto, Shinya Fujita, Yoshiko Uemura, Kazuichi Okazaki

Published in: Clinical Journal of Gastroenterology | Issue 1/2013

Login to get access

Abstract

In June 2008, a 74-year-old male was diagnosed with IgG4-related disease including histologically proven IgG4-related prostatitis, and then followed as an outpatient. In July 2011, cervical, chest, and abdominal computed tomography (CT) revealed right parotid gland swelling and lymph node enlargement of the supraclavicular, mediastinal, left hilar, porta hepatis, and para-aorta. A biopsy of the right parotid gland was performed, and we diagnosed diffuse large B-cell lymphoma (DLBCL). As malignancies are possible complications for patients with IgG4-related disease, we must be careful in the follow-up of IgG4-related disease patients.
Literature
1.
go back to reference Masaki Y, Kurose N, Umehara H, et al. IgG4-related disease: a novel lymphoproliferative disorder discovered and established in Japan in the 21st century. J Clin Exp Hematopathol. 2011;51(1):13–20.CrossRef Masaki Y, Kurose N, Umehara H, et al. IgG4-related disease: a novel lymphoproliferative disorder discovered and established in Japan in the 21st century. J Clin Exp Hematopathol. 2011;51(1):13–20.CrossRef
2.
go back to reference Umehara H, Okazaki K, Masaki Y, Kuwano M, Yamamoto M, Saeki T, Matsui S, Yoshino T, Nakamura S, Kawa S, Hamano H, Kamisawa T, Shimosegawa T, Shimatsu A, Nakamura S, Ito T, Notohara K, Sumida T, Tanaka Y, Mimori T, Chiba T, Mishima M, Hibi T, Tsubouchi H, Inui K, Ohara H, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol. 2012;22(1):21–30. Umehara H, Okazaki K, Masaki Y, Kuwano M, Yamamoto M, Saeki T, Matsui S, Yoshino T, Nakamura S, Kawa S, Hamano H, Kamisawa T, Shimosegawa T, Shimatsu A, Nakamura S, Ito T, Notohara K, Sumida T, Tanaka Y, Mimori T, Chiba T, Mishima M, Hibi T, Tsubouchi H, Inui K, Ohara H, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol. 2012;22(1):21–30.
3.
go back to reference Fukui T, Mitsuyama T, Takaoka M, Uchida K, Matsusita M, Okazaki K, et al. Pancreatic cancer associated with autoimmune pancreatitis in remission. Intern Med. 2007;47:151–5.CrossRef Fukui T, Mitsuyama T, Takaoka M, Uchida K, Matsusita M, Okazaki K, et al. Pancreatic cancer associated with autoimmune pancreatitis in remission. Intern Med. 2007;47:151–5.CrossRef
4.
go back to reference Raffaele Pezzilli, Silvia Veccchiarelli, Maria Cristina Di Marco, Carla Serra, Donatella Santini, Lucia Calclli, Dario Fabbri, Betzabe Rojas Mena, Andrea Imbrogno, et al. Pancreatic ductal adenocarcinoma associated with autoimmune pancreatitis. Case Rep Gastroenterol. 2011;5(2):378–385. Raffaele Pezzilli, Silvia Veccchiarelli, Maria Cristina Di Marco, Carla Serra, Donatella Santini, Lucia Calclli, Dario Fabbri, Betzabe Rojas Mena, Andrea Imbrogno, et al. Pancreatic ductal adenocarcinoma associated with autoimmune pancreatitis. Case Rep Gastroenterol. 2011;5(2):378–385.
5.
go back to reference Gill J, Angelo N, Young ML, McIvor N, et al. Salivary duct carcinoma arising in IgG4-related autoimmune disease of the parotid gland. Hum Pathol. 2009;40(6):761–5.CrossRef Gill J, Angelo N, Young ML, McIvor N, et al. Salivary duct carcinoma arising in IgG4-related autoimmune disease of the parotid gland. Hum Pathol. 2009;40(6):761–5.CrossRef
6.
go back to reference Straub BK, Esposito I, Gotthardt D, Radeleff B, Antolovic D, Flechtenmacher C, et al. IgG4-associated cholangitis with cholangiocarcinoma. Virchows Arch. 2011;458(6):761–5.PubMedCrossRef Straub BK, Esposito I, Gotthardt D, Radeleff B, Antolovic D, Flechtenmacher C, et al. IgG4-associated cholangitis with cholangiocarcinoma. Virchows Arch. 2011;458(6):761–5.PubMedCrossRef
7.
go back to reference Cheuk W, Yuen HK, Chan AC, et al. Ocular adnexal lymphoma associated with IgG4+ chronic sclerosing dacryoadenitis: a previously undescribed complication of IgG4-related sclerosing disease. Am J Surg Pathol. 2008;32:1159–67.PubMedCrossRef Cheuk W, Yuen HK, Chan AC, et al. Ocular adnexal lymphoma associated with IgG4+ chronic sclerosing dacryoadenitis: a previously undescribed complication of IgG4-related sclerosing disease. Am J Surg Pathol. 2008;32:1159–67.PubMedCrossRef
8.
go back to reference Takahashi N, Ghazale AH, Smyrk TC, Mandrekar JN, Chari ST, et al. Possible association between IgG4-associated systemic disease with or without autoimmune pancreatitis and non-Hodgkin lymphoma. Pancreas. 2009;38:523–6.PubMedCrossRef Takahashi N, Ghazale AH, Smyrk TC, Mandrekar JN, Chari ST, et al. Possible association between IgG4-associated systemic disease with or without autoimmune pancreatitis and non-Hodgkin lymphoma. Pancreas. 2009;38:523–6.PubMedCrossRef
9.
go back to reference Kanda G, Ryu T, Shirai T, Ijichi M, Hishima T, Kitamura S, Bandai Y, et al. Peripheral T-cell lymphoma that developed during the follow-up of IgG4-related disease. Intern Med. 2011;50:155–60.PubMedCrossRef Kanda G, Ryu T, Shirai T, Ijichi M, Hishima T, Kitamura S, Bandai Y, et al. Peripheral T-cell lymphoma that developed during the follow-up of IgG4-related disease. Intern Med. 2011;50:155–60.PubMedCrossRef
10.
go back to reference Yamamoto M, Takashi H, Tabeya T, Suzuki C, Nashiro Y, Ishigami K, et al. Risk of malignancies in IgG4-related disease. Mod Rheumatol. 2012;22(3):414–8. Yamamoto M, Takashi H, Tabeya T, Suzuki C, Nashiro Y, Ishigami K, et al. Risk of malignancies in IgG4-related disease. Mod Rheumatol. 2012;22(3):414–8.
11.
go back to reference Zintzaras E, Voulgarelis M, Moutsopoulos HM, et al. The risk of lymphoma development in autoimmune disease: a meta-analysis. Arch Intern Med. 2005;165:2337–44.PubMedCrossRef Zintzaras E, Voulgarelis M, Moutsopoulos HM, et al. The risk of lymphoma development in autoimmune disease: a meta-analysis. Arch Intern Med. 2005;165:2337–44.PubMedCrossRef
12.
go back to reference Smedby KE, Baecklund E, Askling J, et al. Malignant lymphoma in autoimmunity and inflammation: a review of risks, risk factors, and lymphoma characteristics. Cancer Epidemiol Biomarkers Prev. 2006;15:2068–77.CrossRef Smedby KE, Baecklund E, Askling J, et al. Malignant lymphoma in autoimmunity and inflammation: a review of risks, risk factors, and lymphoma characteristics. Cancer Epidemiol Biomarkers Prev. 2006;15:2068–77.CrossRef
13.
go back to reference Zhang W, Feng S, Yan S, Zhao Y, Li M, Sun J, et al. Incidence of malignancy in primary Sjogren’s syndrome in Chinese cohort. Rheumatology (Oxford). 2010;49:571–7.CrossRef Zhang W, Feng S, Yan S, Zhao Y, Li M, Sun J, et al. Incidence of malignancy in primary Sjogren’s syndrome in Chinese cohort. Rheumatology (Oxford). 2010;49:571–7.CrossRef
14.
go back to reference Hansen A, Lipsky PE, Dorner T, et al. B-cell lymphoproliferation in chronic inflammatory rheumatic disease. Nat Clin Pract Rheumatol. 2007;3:561–9.PubMedCrossRef Hansen A, Lipsky PE, Dorner T, et al. B-cell lymphoproliferation in chronic inflammatory rheumatic disease. Nat Clin Pract Rheumatol. 2007;3:561–9.PubMedCrossRef
Metadata
Title
A case of IgG4-related disease associated with diffuse large B cell lymphoma
Authors
Toshiyuki Mitsuyama
Akiyoshi Nishio
Makoto Takaoka
Kazushige Uchida
Masaaki Shimatani
Toshiro Fukui
Tsukasa Ikeura
Masaki Koyabu
Hideaki Miyoshi
Takeo Kusuda
Akiko Kurishima
Yuri Fukui
Kimi Sumimoto
Shinya Fujita
Yoshiko Uemura
Kazuichi Okazaki
Publication date
01-02-2013
Publisher
Springer Japan
Published in
Clinical Journal of Gastroenterology / Issue 1/2013
Print ISSN: 1865-7257
Electronic ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-012-0345-y

Other articles of this Issue 1/2013

Clinical Journal of Gastroenterology 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.